Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. | Director | Common Stock | 23.5K | $158K | $6.74 | May 8, 2024 | Direct |
Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TVTX | Travere Therapeutics, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
TVTX | Travere Therapeutics, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
TVTX | Travere Therapeutics, Inc. | May 11, 2022 | 2 | $0 | 4 | May 12, 2022 | Director |
TVTX | Travere Therapeutics, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |